Patent Portfolio
Composition for target gene modification
| Ref. No. | AJ316 |
|---|---|
| Appl. No. (filing date) |
PCT/JP2018/048034(2018/12/27) |
| Pub. No. (Pub. date) |
WO2019/131829(2019/7/4) |
| Priority claim No. (Priority date) |
JP2017-254798(2017/12/28) |
| Patent No. | EP3733844 |
| Inventor | HOTTA Akitsu, etc. |
| Assignee | Kyoto University Takeda/Pharmaceutical Company Limited |
| Title of Invention | Composition for target gene modification |
| Abstract | The present invention relates to a composition that allows the substance used in the CRISPR system to be introduced into cells as an active ingredient. Furthermore, the present invention relates to a method of inducing gene modification at a target locus in a cell using such a composition, for example, a method of preventing or treating muscular dystrophy by modifying the dystrophin gene of a muscle cell. |
| Information (External link) |
https://patents.google.com/patent/JPWO2019131829A1/en?oq=WO2019%2f131829 |
| Tag | Genome Editing |